{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T23:25:48Z","timestamp":1783553148779,"version":"3.55.0"},"reference-count":131,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,11,9]],"date-time":"2024-11-09T00:00:00Z","timestamp":1731110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,9]],"date-time":"2024-11-09T00:00:00Z","timestamp":1731110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s00210-024-03578-7","type":"journal-article","created":{"date-parts":[[2024,11,9]],"date-time":"2024-11-09T09:18:39Z","timestamp":1731143919000},"page":"3213-3240","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Bridging gap in treatment of polycystic ovarian syndrome through drug repurposing: what we achieved and where we are?"],"prefix":"10.1007","volume":"398","author":[{"given":"Popat S.","family":"Kumbhar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Revati","family":"Chavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Snehal","family":"Darekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaustubh","family":"Kolekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anvitha","family":"Sequeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukriti","family":"Vishwas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guarav","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keshav Raj","family":"Paudel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachin Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamal","family":"Dua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Disouza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vandana","family":"Patravale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,9]]},"reference":[{"key":"3578_CR1","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1586\/eog.11.30","volume":"6","author":"J Al-Shalati","year":"2011","unstructured":"Al-Shalati J, Tulandi T (2011) The use of aromatase inhibitors in infertility and gynecology. Expert Rev Obstet Gynecol 6:415\u2013421. https:\/\/doi.org\/10.1586\/eog.11.30","journal-title":"Expert Rev Obstet Gynecol"},{"key":"3578_CR2","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1093\/humrep\/dex227","volume":"32","author":"SA Amer","year":"2017","unstructured":"Amer SA, Smith J, Mahran A, Fox P, Fakis A (2017) Double-blind randomized controlled trial of letrozole versus clomiphene citrate in subfertile women with polycystic ovarian syndrome. Hum Reprod (Oxford, England) 32:1631\u20131638. https:\/\/doi.org\/10.1093\/humrep\/dex227","journal-title":"Hum Reprod (Oxford, England)"},{"key":"3578_CR3","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1080\/03639045.2023.2216785","volume":"49","author":"RM Ardad","year":"2023","unstructured":"Ardad RM, Manjappa AS, Dhawale SC, Kumbhar PS, Pore YV (2023) Concurrent oral delivery of non-oncology drugs through solid self-emulsifying system for repurposing in hepatocellular carcinoma. Drug Dev Ind Pharm 49:377\u2013391. https:\/\/doi.org\/10.1080\/03639045.2023.2216785","journal-title":"Drug Dev Ind Pharm"},{"key":"3578_CR4","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1080\/14656566.2016.1215430","volume":"17","author":"D Armanini","year":"2016","unstructured":"Armanini D, Andrisani A, Bordin L, Sabbadin C (2016) Spironolactone in the treatment of polycystic ovary syndrome. Expert Opin Pharmacother 17:1713\u20131715. https:\/\/doi.org\/10.1080\/14656566.2016.1215430","journal-title":"Expert Opin Pharmacother"},{"key":"3578_CR5","doi-asserted-by":"publisher","first-page":"4110","DOI":"10.3390\/ijms23084110","volume":"23","author":"D Armanini","year":"2022","unstructured":"Armanini D, Boscaro M, Bordin L, Sabbadin C (2022) Controversies in the pathogenesis, diagnosis and treatment of PCOS: Focus on insulin resistance, inflammation, and hyperandrogenism. Int J Mol Sci 23:4110. https:\/\/doi.org\/10.3390\/ijms23084110","journal-title":"Int J Mol Sci"},{"key":"3578_CR6","doi-asserted-by":"publisher","first-page":"3493","DOI":"10.1210\/jc.2011-0501","volume":"96","author":"B Banaszewska","year":"2011","unstructured":"Banaszewska B, Pawelczyk L, Spaczynski RZ, Duleba AJ (2011) Effects of simvastatin and metformin on polycystic ovary syndrome after 6 months of treatment. J Clin Endocrinol Metab 96:3493\u20133501. https:\/\/doi.org\/10.1210\/jc.2011-0501","journal-title":"J Clin Endocrinol Metab"},{"key":"3578_CR7","doi-asserted-by":"publisher","first-page":"4322","DOI":"10.1210\/jc.2016-1858","volume":"101","author":"B Banaszewska","year":"2016","unstructured":"Banaszewska B, Wroty\u0144ska-Barczy\u0144ska J, Spaczynski RZ, Pawelczyk L, Duleba AJ (2016) Effects of resveratrol on polycystic ovary syndrome: A double-blind, randomized, placebo-controlled trial. J Clin Endocrinol Metab 101:4322\u20134328. https:\/\/doi.org\/10.1210\/jc.2016-1858","journal-title":"J Clin Endocrinol Metab"},{"key":"3578_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.47363\/JDCRS\/2022(3)126","volume":"3","author":"G Bereda","year":"2022","unstructured":"Bereda G (2022) Clinical Pharmacology of Spironolactone. J Diagn Case Rep 3:1\u20134","journal-title":"J Diagn Case Rep"},{"key":"3578_CR9","doi-asserted-by":"publisher","first-page":"6180","DOI":"10.1038\/s41598-024-56524-1","volume":"14","author":"E Berenji","year":"2024","unstructured":"Berenji E, ValipourMotlagh A, Fathi M, Esmaeili M, Izadi T, Rezvanian P, Zanjirband M, Safaeinejad Z, Nasr-Esfahani MH (2024) Discovering therapeutic possibilities for polycystic ovary syndrome by targeting XIST and its associated ceRNA network through the analysis of transcriptome data. Sci Rep 14:6180. https:\/\/doi.org\/10.1038\/s41598-024-56524-1","journal-title":"Sci Rep"},{"key":"3578_CR10","doi-asserted-by":"publisher","first-page":"e32351","DOI":"10.7759\/cureus.32351","volume":"14","author":"MD Bharali","year":"2022","unstructured":"Bharali MD, Rajendran R, Goswami J, Singal K, Rajendran V (2022) Prevalence of polycystic ovarian syndrome in India: a systematic review and meta-analysis. Cureus 14:e32351. https:\/\/doi.org\/10.7759\/cureus.32351","journal-title":"Cureus"},{"key":"3578_CR11","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/dom.14583","volume":"24","author":"M Cai","year":"2022","unstructured":"Cai M, Shao X, Xing F, Zhang Y, Gao X, Zeng Q, Dilimulati D, Qu S, Zhang M (2022) Efficacy of canagliflozin versus metformin in women with polycystic ovary syndrome: A randomized, open-label, noninferiority trial. Diabetes Obes Metab 24:312\u2013320. https:\/\/doi.org\/10.1111\/dom.14583","journal-title":"Diabetes Obes Metab"},{"key":"3578_CR12","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1111\/cen.12557","volume":"81","author":"S Cassar","year":"2014","unstructured":"Cassar S, Teede HJ, Moran LJ, Joham AE, Harrison CL, Strauss BJ, Stepto NK (2014) Polycystic ovary syndrome and anti-M\u00fcllerian hormone: role of insulin resistance, androgens, obesity and gonadotrophins. Clin Endocrinol 81:899\u2013906. https:\/\/doi.org\/10.1111\/cen.12557","journal-title":"Clin Endocrinol"},{"key":"3578_CR13","doi-asserted-by":"publisher","first-page":"e26289","DOI":"10.1097\/MD.0000000000026289","volume":"100","author":"LL Chen","year":"2021","unstructured":"Chen LL, Zheng JH (2021) Effects of atorvastatin on the insulin resistance in women of polycystic ovary syndrome: A systematic review and meta-analysis: A systematic review and meta-analysis. Medicine 100:e26289. https:\/\/doi.org\/10.1097\/MD.0000000000026289","journal-title":"Medicine"},{"key":"3578_CR14","doi-asserted-by":"publisher","first-page":"4476","DOI":"10.3390\/molecules27144476","volume":"27","author":"T Chen","year":"2022","unstructured":"Chen T, Jia F, Yu Y, Zhang W, Wang C, Zhu S, Zhang N, Liu X (2022) Potential role of quercetin in polycystic ovary syndrome and its complications: A review. Molecules (Basel, Switzerland) 27:4476. https:\/\/doi.org\/10.3390\/molecules27144476","journal-title":"Molecules (Basel, Switzerland)"},{"key":"3578_CR15","doi-asserted-by":"publisher","first-page":"110644","DOI":"10.1016\/j.mehy.2021.110644","volume":"154","author":"L Corrie","year":"2021","unstructured":"Corrie L, Gulati M, Vishwas S, KapoorB SSK, Awasthi A, Khursheed R (2021) Combination therapy of curcumin and fecal microbiota transplant: Potential treatment of polycystic ovarian syndrome. Med Hypotheses 154:110644. https:\/\/doi.org\/10.1016\/j.mehy.2021.110644","journal-title":"Med Hypotheses"},{"key":"3578_CR16","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2174\/1573404818666220329123334","volume":"19","author":"L Corrie","year":"2023","unstructured":"Corrie L, Singh SK, Gulati M, Awasthi A, Khursheed R, Kaur J, Vishwas S (2023a) Improvement in polycystic ovarian syndrome using pharmacological and non-pharmacological approaches: Current perspectives and principles. Curr Womens Health Rev 19:11\u201318","journal-title":"Curr Womens Health Rev"},{"key":"3578_CR17","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3390\/ph16020197","volume":"16","author":"L Corrie","year":"2023","unstructured":"Corrie L, Awasthi A, Kaur J, Vishwas S, Gulati M, Kaur IP, Gupta G, Kommineni N, Dua K, Singh SK (2023b) Interplay of gut Microbiota in polycystic Ovarian Syndrome: Role of gut Microbiota, mechanistic pathways and potential treatment strategies. Pharmaceuticals (Basel, Switzerland) 16:197. https:\/\/doi.org\/10.3390\/ph16020197","journal-title":"Pharmaceuticals (Basel, Switzerland)"},{"key":"3578_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-024-03029-3","author":"L Corrie","year":"2024","unstructured":"Corrie L, Singh H, Gulati M, Vishwas S, Chellappan DK, Gupta G, Paiva-Santos AC, Veiga F, Alotaibi F, Alam A, Eri RD, Prasher P, Adams J, Paudel KR, DuaK SSK (2024) Polysaccharide-fecal microbiota-based colon-targeted self-nanoemulsifying drug delivery system of curcumin for treating polycystic ovarian syndrome. Naunyn-Schmiedeberg\u2019s Arch Pharmacol. https:\/\/doi.org\/10.1007\/s00210-024-03029-3","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"3578_CR19","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1515\/jbcpp-2020-0107","volume":"32","author":"N Devi","year":"2020","unstructured":"Devi N, Boya C, Chhabra M, Bansal D (2020) N-acetyl-cysteine as adjuvant therapy in female infertility: a systematic review and meta-analysis. J Basic Clin Physiol Pharmacol 32:899\u2013910. https:\/\/doi.org\/10.1515\/jbcpp-2020-0107","journal-title":"J Basic Clin Physiol Pharmacol"},{"key":"3578_CR20","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13098-023-00983-5","volume":"15","author":"S Dhankhar","year":"2023","unstructured":"Dhankhar S, Chauhan S, Mehta DK, Nitika Saini K, Saini M, Das R, Gupta S, Gautam V (2023) Novel targets for potential therapeutic use in Diabetes mellitus. Diabetol Metab Syndr 15:17. https:\/\/doi.org\/10.1186\/s13098-023-00983-5","journal-title":"Diabetol Metab Syndr"},{"key":"3578_CR21","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s00418-006-0265-3","volume":"127","author":"E Diamanti-Kandarakis","year":"2007","unstructured":"Diamanti-Kandarakis E, Piperi C, Patsouris E, Korkolopoulou P, Panidis D, Pawelczyk L, Papavassiliou AG, Duleba AJ (2007) Immunohistochemical localization of advanced glycation end-products (AGEs) and their receptor (RAGE) in polycystic and normal ovaries. Histochem Cell Biol 127:581\u2013589. https:\/\/doi.org\/10.1007\/s00418-006-0265-3","journal-title":"Histochem Cell Biol"},{"key":"3578_CR22","doi-asserted-by":"publisher","first-page":"94","DOI":"10.5114\/pm.2019.84039","volume":"18","author":"K Doroszewska","year":"2019","unstructured":"Doroszewska K, Milewicz T, Mrozi\u0144ska S, Janeczko J, Rokicki R, Janeczko M, Warzecha D, Marianowski P (2019) Blood pressure in postmenopausal women with a history of polycystic ovary syndrome. PrzegladMenopauzalny 18:94\u201398. https:\/\/doi.org\/10.5114\/pm.2019.84039","journal-title":"PrzegladMenopauzalny"},{"key":"3578_CR23","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1007\/s12325-012-0044-6","volume":"29","author":"Q Du","year":"2012","unstructured":"Du Q, Yang S, Wang YJ, Wu B, Zhao YY, Fan B (2012) Effects of thiazolidinediones on polycystic ovary syndrome: a meta-analysis of randomized placebo-controlled trials. Adv Ther 29:763\u2013774. https:\/\/doi.org\/10.1007\/s12325-012-0044-6","journal-title":"Adv Ther"},{"key":"3578_CR24","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.3390\/antibiotics11111628","volume":"11","author":"A Duda-Madej","year":"2022","unstructured":"Duda-Madej A, Stecko J, Sobieraj J, Szyma\u0144ska N, Koz\u0142owska J (2022) Naringenin and its derivatives-health-promoting phytobiotic against resistant bacteria and fungi in humans. Antibiotics (Basel, Switzerland) 11:1628. https:\/\/doi.org\/10.3390\/antibiotics11111628","journal-title":"Antibiotics (Basel, Switzerland)"},{"key":"3578_CR25","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1210\/jc.2015-3780","volume":"101","author":"A Dunaif","year":"2016","unstructured":"Dunaif A (2016) Perspectives in polycystic ovary syndrome: From hair to eternity. J Clin Endocrinol Metab 101:759\u2013768. https:\/\/doi.org\/10.1210\/jc.2015-3780","journal-title":"J Clin Endocrinol Metab"},{"key":"3578_CR26","doi-asserted-by":"publisher","first-page":"102697","DOI":"10.1016\/j.dsx.2022.102697","volume":"17","author":"D Dutta","year":"2023","unstructured":"Dutta D, Bhattacharya S, Kumar M, Datta PK, Mohindra R, Sharma M (2023) Efficacy and safety of novel thiazolidinedione lobeglitazone for managing type-2 diabetes a meta-analysis. Diabetes Metabo Syndr 17:102697. https:\/\/doi.org\/10.1016\/j.dsx.2022.102697","journal-title":"Diabetes Metabo Syndr"},{"key":"3578_CR27","doi-asserted-by":"publisher","first-page":"3019","DOI":"10.1210\/clinem\/dgab408","volume":"106","author":"KE Elkind-Hirsch","year":"2021","unstructured":"Elkind-Hirsch KE, Chappell N, Seidemann E, Storment J, Bellanger D (2021) Exenatide, dapagliflozin, or phentermine\/topiramate differentially affect metabolic profiles in polycystic ovary syndrome. J Clin Endocrinol Metab 106:3019\u20133033. https:\/\/doi.org\/10.1210\/clinem\/dgab408","journal-title":"J Clin Endocrinol Metab"},{"key":"3578_CR28","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.fertnstert.2022.04.027","volume":"118","author":"KE Elkind-Hirsch","year":"2022","unstructured":"Elkind-Hirsch KE, Chappell N, Shaler D, Storment J, Bellanger D (2022) Liraglutide 3 mg on weight, body composition, and hormonal and metabolic parameters in women with obesity and polycystic ovary syndrome: a randomized placebo-controlled-phase 3 study. Fertil Steril 118:371\u2013381. https:\/\/doi.org\/10.1016\/j.fertnstert.2022.04.027","journal-title":"Fertil Steril"},{"key":"3578_CR29","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/nrendo.2018.24","volume":"14","author":"HF Escobar-Morreale","year":"2018","unstructured":"Escobar-Morreale HF (2018) Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol 14:270\u2013284. https:\/\/doi.org\/10.1038\/nrendo.2018.24","journal-title":"Nat Rev Endocrinol"},{"key":"3578_CR30","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13048-020-00670-3","volume":"13","author":"F Fang","year":"2020","unstructured":"Fang F, Li YM (2020) Role of gut microbiota in the development of insulin resistance and the mechanism underlying polycystic ovary syndrome: a review. J Ovarian Res 13:73","journal-title":"J Ovarian Res"},{"key":"3578_CR31","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1093\/ejendo\/lvad082","volume":"189","author":"M Forslund","year":"2023","unstructured":"Forslund M, Melin J, Alesi S, Piltonen T, Romualdi D, Tay CT, Witchel S, Pena A, Mousa A, Teede H (2023) Different kinds of oral contraceptive pills in polycystic ovary syndrome: a systematic review and meta-analysis. Eur J Endocrinol 189:S1\u2013S16. https:\/\/doi.org\/10.1093\/ejendo\/lvad082","journal-title":"Eur J Endocrinol"},{"issue":"22","key":"3578_CR32","doi-asserted-by":"publisher","first-page":"4871","DOI":"10.3390\/nu14224871","volume":"14","author":"AI Foudah","year":"2022","unstructured":"Foudah AI, Devi S, Alqarni MH, Alam A, Salkini MA, Kumar M, Almalki HS (2022) Quercetin Attenuates Nitroglycerin-Induced Migraine Headaches by Inhibiting Oxidative Stress and Inflammatory Mediators. Nutrients 14(22):4871. https:\/\/doi.org\/10.3390\/nu14224871","journal-title":"Nutrients"},{"key":"3578_CR33","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1210\/jc.2010-2618","volume":"96","author":"PA Fowler","year":"2011","unstructured":"Fowler PA, Anderson RA, Saunders PT, KinnellH MJI, Evans DB, Bhattacharya S, Flannigan S, Franks S, Monteiro A, O\u2019Shaughnessy PJ (2011) Development of steroid signaling pathways during primordial follicle formation in the human fetal ovary. J Clin Endocrinol Metab 96:1754\u20131762. https:\/\/doi.org\/10.1210\/jc.2010-2618","journal-title":"J Clin Endocrinol Metab"},{"key":"3578_CR34","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.1210\/jc.2003-031780","volume":"89","author":"MA Ganie","year":"2004","unstructured":"Ganie MA, Khurana ML, Eunice M, Gupta N, Gulati M, Dwivedi SN, Ammini AC (2004) Comparison of efficacy of spironolactone with metformin in the management of polycystic ovary syndrome: an open-labeled study. J Clin Endocrinol Metab 89:2756\u20132762. https:\/\/doi.org\/10.1210\/jc.2003-031780","journal-title":"J Clin Endocrinol Metab"},{"key":"3578_CR35","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s10815-011-9564-2","volume":"28","author":"S Ghandi","year":"2011","unstructured":"Ghandi S, Aflatoonian A, Tabibnejad N, Moghaddam MHS (2011) The effects of metformin or orlistat on obese women with polycystic ovary syndrome: a prospective randomized open-label study. J Assist Reprod Genet 28:591\u2013596. https:\/\/doi.org\/10.1007\/s10815-011-9564-2","journal-title":"J Assist Reprod Genet"},{"key":"3578_CR36","doi-asserted-by":"publisher","first-page":"13704","DOI":"10.1111\/obr.13704","volume":"25","author":"A Goldberg","year":"2024","unstructured":"Goldberg A, Graca S, Liu J, Rao V, Witchel SF, Pena A, Li R, Mousa A, Tay CT, Pattuwage L, Teede H, Yildiz BO, Ee C (2024) Anti-obesity pharmacological agents for polycystic ovary syndrome: A systematic review and meta-analysis to inform the 2023 international evidence-based guideline. Obes Rev 25:13704. https:\/\/doi.org\/10.1111\/obr.13704","journal-title":"Obes Rev"},{"key":"3578_CR37","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.semcancer.2019.12.012","volume":"68","author":"A Gonzalez-Fierro","year":"2021","unstructured":"Gonzalez-Fierro A, Due\u00f1as-Gonz\u00e1lez A (2021) Drug repurposing for cancer therapy, easier said than done. Semin Cancer Biol 68:123\u2013131. https:\/\/doi.org\/10.1016\/j.semcancer.2019.12.012","journal-title":"Semin Cancer Biol"},{"issue":"18","key":"3578_CR38","doi-asserted-by":"publisher","first-page":"E1319","DOI":"10.1503\/cmaj.110463","volume":"183","author":"N Gronich","year":"2011","unstructured":"Gronich N, Lavi I, Rennert G (2011) Higher risk of venous thrombosis associated with drospirenone-containing oral contraceptives: a population-based cohort study. CMAJ 183(18):E1319-25. https:\/\/doi.org\/10.1503\/cmaj.110463","journal-title":"CMAJ"},{"issue":"3","key":"3578_CR39","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/0006-2952(87)90288-7","volume":"36","author":"RJ Gryglewski","year":"1987","unstructured":"Gryglewski RJ, Korbut R, Robak J, \u015awi\u0229s J (1987) On the mechanism of antithrombotic action of flavonoids. Biochem Pharmacol 36(3):317\u2013322. https:\/\/doi.org\/10.1016\/0006-2952(87)90288-7","journal-title":"Biochem Pharmacol"},{"key":"3578_CR40","doi-asserted-by":"publisher","first-page":"e10786","DOI":"10.1016\/j.heliyon.2022.e10786","volume":"8","author":"W Han","year":"2022","unstructured":"Han W, Shi CT, Ma J, Chen H, Shao QX, Gao XJ, Zhou Y, Gu JF, Wang HN (2022) Pan-cancer analysis of LncRNA XIST and its potential mechanisms in human cancers. Heliyon 8:e10786. https:\/\/doi.org\/10.1016\/j.heliyon.2022.e10786","journal-title":"Heliyon"},{"key":"3578_CR41","doi-asserted-by":"publisher","first-page":"e34671","DOI":"10.1097\/MD.0000000000034671","volume":"102","author":"X Hao","year":"2023","unstructured":"Hao X, Zhu X, Tian H, Lai G, Zhang W, Zhou H, Liu S (2023) Pharmacological effect and mechanism of orlistat in anti-tumor therapy: A review. Medicine 102:e34671. https:\/\/doi.org\/10.1097\/MD.0000000000034671","journal-title":"Medicine"},{"key":"3578_CR42","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.rbmo.2015.09.015","volume":"32","author":"H Hashim","year":"2016","unstructured":"Hashim H (2016) Twenty years of ovulation induction with metformin for PCOS. Reprod Biomed Online 32:44\u201353","journal-title":"Reprod Biomed Online"},{"key":"3578_CR43","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1080\/09513590.2021.2003326","volume":"38","author":"JL Hern\u00e1ndez-Jim\u00e9nez","year":"2022","unstructured":"Hern\u00e1ndez-Jim\u00e9nez JL, Barrera D, Espinoza-Sim\u00f3n E, Gonz\u00e1lez J, Ort\u00edz-Hern\u00e1ndez R, Escobar L, Echeverr\u00eda O, Torres-Ram\u00edrez N (2022) Polycystic ovarian syndrome: signs and feedback effects of hyperandrogenism and insulin resistance. Gynecol Endocrinol 38:2\u20139. https:\/\/doi.org\/10.1080\/09513590.2021.2003326","journal-title":"Gynecol Endocrinol"},{"key":"3578_CR44","doi-asserted-by":"publisher","first-page":"e943403","DOI":"10.12659\/MSM.943403","volume":"30","author":"Y Hong","year":"2023","unstructured":"Hong Y, Yin Y, Tan Y, Hong K, Zhou H (2023) Retracted: The flavanone, naringenin, modifies antioxidant and steroidogenic enzyme activity in a rat model of letrozole-induced polycystic ovary syndrome. Med Sci Monit 30:e943403. https:\/\/doi.org\/10.12659\/MSM.943403","journal-title":"Med Sci Monit"},{"key":"3578_CR45","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jnutbio.2017.04.012","volume":"47","author":"T Hu","year":"2017","unstructured":"Hu T, Yuan X, Ye R, Zhou H, Lin J, Zhang C, Zhang H, Wei G, Dong M, Huang Y, Lim W, Liu Q, Lee HJ, Jin W (2017) Brown adipose tissue activation by rutin ameliorates polycystic ovary syndrome in rat. J Nutr Biochem 47:21\u201328. https:\/\/doi.org\/10.1016\/j.jnutbio.2017.04.012","journal-title":"J Nutr Biochem"},{"key":"3578_CR46","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1111\/j.1365-4632.2007.03270.x","volume":"46","author":"J Jackson","year":"2007","unstructured":"Jackson J, Caro J, Caro G, Garfield F, Huber F, Zhou W (2007) EflornithineHCl Study Group. The effect of eflornithine 13.9% cream on the bother and dicomfort due to hirsutism. Int J Dermatol 46:976\u2013981","journal-title":"Int J Dermatol"},{"key":"3578_CR47","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13048-016-0295-y","volume":"9","author":"S Jahan","year":"2016","unstructured":"Jahan S, Munir F, Razak S, Mehboob A, Ain Q, Ullah H, Afsar T, Shaheen G, Almajwal A (2016) Ameliorative effects of rutin against metabolic, biochemical and hormonal disturbances in polycystic ovary syndrome in rats. J Ovarian Res 9:86. https:\/\/doi.org\/10.1186\/s13048-016-0295-y","journal-title":"J Ovarian Res"},{"key":"3578_CR48","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1111\/cen.13968","volume":"90","author":"Z Javed","year":"2019","unstructured":"Javed Z, Papageorgiou M, Deshmukh H, Rigby AS, Qamar U, Abbas J, Khan AY, Kilpatrick ES, Atkin SL, Sathyapalan T (2019) Effects of empagliflozin on metabolic parameters in polycystic ovary syndrome: A randomized controlled study. Clin Endocrinol 90:805\u2013813. https:\/\/doi.org\/10.1111\/cen.13968","journal-title":"Clin Endocrinol"},{"key":"3578_CR49","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1111\/dom.14944","volume":"25","author":"M Jensterle","year":"2023","unstructured":"Jensterle M, Ferjan S, Le\u017eai\u010d L, So\u010dan A, Gori\u010dar K, Zaletel K, Janez A (2023) Semaglutide delays 4-hour gastric emptying in women with polycystic ovary syndrome and obesity. Diabetes Obes Metab 25:975\u2013984. https:\/\/doi.org\/10.1111\/dom.14944","journal-title":"Diabetes Obes Metab"},{"key":"3578_CR50","doi-asserted-by":"publisher","first-page":"105606","DOI":"10.1016\/j.tiv.2023.105606","volume":"90","author":"R Kato","year":"2023","unstructured":"Kato R, Yamada T, Noda T, Tanaka S, Kohda Y, Ijiri Y (2023) Mechanism of non-steroidal anti-androgen-induced liver injury: Reactive metabolites of flutamide and bicalutamide activate inflammasomes. Toxicol In Vitro 90:105606. https:\/\/doi.org\/10.1016\/j.tiv.2023.105606","journal-title":"Toxicol In Vitro"},{"key":"3578_CR51","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1055\/s-0029-1220770","volume":"118","author":"C Kaya","year":"2010","unstructured":"Kaya C, Pabuccu R, Cengiz SD, D\u00fcnder I (2010) Comparison of the effects of atorvastatin and simvastatin in women with polycystic ovary syndrome: A prospective, randomized study. Exp Clin Endocrinol Diabetes 118:161\u2013166. https:\/\/doi.org\/10.1055\/s-0029-1220770","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"3578_CR52","doi-asserted-by":"publisher","first-page":"e93805","DOI":"10.1371\/journal.pone.0093805","volume":"9","author":"CC Keefe","year":"2014","unstructured":"Keefe CC, Goldman MM, Zhang K, Clarke N, Reitz RE, Welt CK (2014) Simultaneous measurement of thirteen steroid hormones in women with polycystic ovary syndrome and control women using liquid chromatography-tandem mass spectrometry. PLoS One 9:e93805. https:\/\/doi.org\/10.1371\/journal.pone.0093805","journal-title":"PLoS One"},{"key":"3578_CR53","first-page":"1771","volume":"68","author":"P Kodaman","year":"2008","unstructured":"Kodaman P, Duleba A (2008) HMG-CoA reductase inhibitors: do they have potential in the treatment of polycystic ovary syndrome? Drugs. Springer 68:1771\u20131785","journal-title":"Springer"},{"key":"3578_CR54","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.jconrel.2022.07.039","volume":"349","author":"P Kumbhar","year":"2022","unstructured":"Kumbhar P, Kole K, Khadake V, Marale P, Manjappa A, Nadaf S, Jadhav R, Patil A, Singh SK, Dua K, Jha NK, Disouza J, Patravale V (2022a) Nanoparticulate drugs and vaccines: Breakthroughs and bottlenecks of repurposing in breast cancer. J Control Release 349:812\u2013830. https:\/\/doi.org\/10.1016\/j.jconrel.2022.07.039","journal-title":"J Control Release"},{"key":"3578_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jconrel.2021.11.015","volume":"341","author":"P Kumbhar","year":"2022","unstructured":"Kumbhar P, Manjappa A, Shah R, Jha NK, Singh SK, Dua K, Disouza J, Patravale V (2022b) Inhalation delivery of repurposed drugs for lung cancer: Approaches, benefits and challenges. J Control Release 341:1\u201315. https:\/\/doi.org\/10.1016\/j.jconrel.2021.11.015","journal-title":"J Control Release"},{"key":"3578_CR56","doi-asserted-by":"publisher","first-page":"175031","DOI":"10.1016\/j.ejphar.2022.175031","volume":"926","author":"P Kumbhar","year":"2023","unstructured":"Kumbhar P, Kole K, Yadav T, Bhavar A, Waghmare P, Bhokare R, Manjappa A, Jha NK, Chellappan DK, Shinde S, Singh SK, Dua K, Salawi A, Disouza J, Patravale V (2023a) Drug repurposing: An emerging strategy in alleviating skin cancer. Eur J Pharmacol 926:175031. https:\/\/doi.org\/10.1016\/j.ejphar.2022.175031","journal-title":"Eur J Pharmacol"},{"key":"3578_CR57","doi-asserted-by":"publisher","first-page":"108310","DOI":"10.1016\/j.microc.2022.108310","volume":"185","author":"P Kumbhar","year":"2023","unstructured":"Kumbhar P, Waghmare P, Nadaf S, Manjappa A, Shah R, Disouza J (2023b) QbD and Six Sigma quality approach for chromatographic estimation of repurposed simvastatin from nanostructured lipid carriers. Microchem J 185:108310. https:\/\/doi.org\/10.1016\/j.microc.2022.108310. (Devoted to the Application of Microtechniques in All Branches of Science)","journal-title":"Microchem J"},{"key":"3578_CR58","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1208\/s12249-023-02565-0","volume":"24","author":"PS Kumbhar","year":"2023","unstructured":"Kumbhar PS, Manjappa AS, Shah RR, Nadaf SJ, Disouza JI (2023c) Nanostructured lipid carrier-based gel for repurposing simvastatin in localized treatment of breast cancer: Formulation design, development, and in vitro and in vivo characterization. AAPS PharmSciTech 24:106. https:\/\/doi.org\/10.1208\/s12249-023-02565-0","journal-title":"AAPS PharmSciTech"},{"key":"3578_CR59","doi-asserted-by":"crossref","unstructured":"Kumbhar P, Kole K, Manjappa A, Jha NK, Disouza J, Patravale V (2023d) Drug Repurposing Opportunities in Cancer. In: Drug Repurposing for Emerging Infectious Diseases and Cancer. Nature, p 53\u201387","DOI":"10.1007\/978-981-19-5399-6_5"},{"key":"3578_CR60","doi-asserted-by":"publisher","unstructured":"Kumbhar P, Kolekar K, Vishwas S, Shetti, P, Kumbar V, Andreoli Pinto T. de J, Paiva-Santos AC, Veiga F, Gupta G, Singh SK, Dua K, Disouza J, Patravale V (2024) Treatment avenues for age-related macular degeneration: Breakthroughs and bottlenecks. Ageing Res Rev 102322. https:\/\/doi.org\/10.1016\/j.arr.2024.102322","DOI":"10.1016\/j.arr.2024.102322"},{"key":"3578_CR61","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1080\/713603187","volume":"17","author":"EM Lakryc","year":"2003","unstructured":"Lakryc EM, Motta ELA, SoaresJM JMA, de Lima GR, Baracat EC (2003) The benefits of finasteride for hirsute women with polycystic ovary syndrome or idiopathic hirsutism. Gynecol Endocrinol 17:57\u201363. https:\/\/doi.org\/10.1080\/713603187","journal-title":"Gynecol Endocrinol"},{"key":"3578_CR62","doi-asserted-by":"publisher","first-page":"100193","DOI":"10.1016\/j.advnut.2024.100193","volume":"15","author":"S Lalonde-Bester","year":"2024","unstructured":"Lalonde-Bester S, Malik M, Masoumi R, Ng K, Sidhu S, Ghosh M, Vine D (2024) Prevalence and etiology of eating disorders in polycystic ovary syndrome: A scoping review. Adv Nutr (Bethesda, Md.) 15:100193. https:\/\/doi.org\/10.1016\/j.advnut.2024.100193","journal-title":"Adv Nutr (Bethesda, Md.)"},{"key":"3578_CR63","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1177\/2042018810380215","volume":"1","author":"H Lashen","year":"2010","unstructured":"Lashen H (2010) Role of metformin in the management of polycystic ovary syndrome. Ther Adv Endocrinol Metab 1:117\u2013128. https:\/\/doi.org\/10.1177\/2042018810380215","journal-title":"Ther Adv Endocrinol Metab"},{"key":"3578_CR64","doi-asserted-by":"publisher","first-page":"716","DOI":"10.21037\/cdt-21-110","volume":"11","author":"Y Li","year":"2021","unstructured":"Li Y, Yuan X, Shi Z, Wang H, Ren D, Zhang Y, Fan Y, Liu Y, Cui Z (2021) LncRNA XIST serves as a diagnostic biomarker in gestational diabetes mellitus and its regulatory effect on trophoblast cell via miR-497\u20135p\/FOXO1 axis. Cardiovasc Diagn Ther 11:716\u2013725. https:\/\/doi.org\/10.21037\/cdt-21-110","journal-title":"Cardiovasc Diagn Ther"},{"key":"3578_CR65","doi-asserted-by":"publisher","first-page":"d6423","DOI":"10.1136\/bmj.d6423","volume":"343","author":"\u00d8 Lidegaard","year":"2001","unstructured":"Lidegaard \u00d8, Nielsen L, Skovlund C, Skjeldestad F, L\u00f8kkegaard E (2001) Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study,\u00a0 2001-9. BMJ 343:d6423. https:\/\/doi.org\/10.1136\/bmj.d6423","journal-title":"BMJ"},{"issue":"3","key":"3578_CR66","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1111\/jch.14645","volume":"25","author":"HT Liu","year":"2023","unstructured":"Liu HT, Deng NH, Wu ZF, Zhou ZY, Tian Z, Liu XY, Wang YX, Zheng HY, Ou YS, Jiang ZS (2023) Statin\u2019s role on blood pressure levels: Meta-analysis based on randomized controlled trials. J Clin Hypertens 25(3):238\u2013250. https:\/\/doi.org\/10.1111\/jch.14645","journal-title":"J Clin Hypertens"},{"key":"3578_CR67","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s12020-014-0200-7","volume":"47","author":"S Livadas","year":"2014","unstructured":"Livadas S, Pappas C, Karachalios A, Marinakis E, Tolia N, Drakou M (2014) Prevalence and impact of hyperandrogenemia in 1218 women with polycystic ovary syndrome. Endocrine 47:631\u2013638","journal-title":"Endocrine"},{"key":"3578_CR68","doi-asserted-by":"publisher","first-page":"1065243","DOI":"10.3389\/fphar.2022.1065243","volume":"13","author":"ED Luo","year":"2022","unstructured":"Luo ED, Jiang HM, Chen W, Wang Y, Tang M, Guo WM, Diao HY, Cai NY, Yang X, Bian Y, Xing SS (2022) Advancements in lead therapeutic phytochemicals polycystic ovary syndrome: A review. Front Pharmacol 13:1065243. https:\/\/doi.org\/10.3389\/fphar.2022.1065243","journal-title":"Front Pharmacol"},{"key":"3578_CR69","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12902-020-00569-6","volume":"20","author":"PP Lv","year":"2020","unstructured":"Lv PP, Jin M, Rao JP, Chen J, Wang LQ, Huang CC, Yang SQ, Yao QP, Feng L, Shen JM, Feng C (2020) Role of anti-M\u00fcllerian hormone and testosterone in follicular growth: a cross-sectional study. BMC Endocr Disord 20:101. https:\/\/doi.org\/10.1186\/s12902-020-00569-6","journal-title":"BMC Endocr Disord"},{"key":"3578_CR70","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1530\/eje.1.02331","volume":"156","author":"A Majuri","year":"2007","unstructured":"Majuri A, Santaniemi M, Rautio K, Kunnari A, Vartiainen J, Ruokonen A, Kes\u00e4niemi YA, Tapanainen JS, Ukkola O, Morin-Papunen L (2007) Rosiglitazone treatment increases plasma levels of adiponectin and decreases levels of resistin in overweight women with PCOS: a randomized placebo-controlled study. Eur J Endocrinol 156:263\u2013269. https:\/\/doi.org\/10.1530\/eje.1.02331","journal-title":"Eur J Endocrinol"},{"key":"3578_CR71","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ejogrb.2012.10.015","volume":"166","author":"M Maliqueo","year":"2013","unstructured":"Maliqueo M, Lara HE, S\u00e1nchez F, Echibur\u00fa B, Crisosto N, Sir-Petermann T (2013) Placental steroidogenesis in pregnant women with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 166:151\u2013155. https:\/\/doi.org\/10.1016\/j.ejogrb.2012.10.015","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"3578_CR72","doi-asserted-by":"publisher","first-page":"6509","DOI":"10.4049\/jimmunol.164.12.6509","volume":"164","author":"S Manna","year":"2000","unstructured":"Manna S, Mukhopadhyay A, Aggarwal B (2000) Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-\u03baB, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation. J Immunol 164:6509\u20136519","journal-title":"J Immunol"},{"key":"3578_CR73","first-page":"3561","volume":"12","author":"S Marbaniang","year":"2023","unstructured":"Marbaniang S, Singh A, Kshetrimayum V, Naorem S, Rosyka L (2023) Study of lipid profile in polycystic ovarian syndrome: a case control study in tertiary care hospital. Int J Reprod 12:3561\u20133566","journal-title":"Int J Reprod"},{"key":"3578_CR74","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1093\/humupd\/dms003","volume":"18","author":"M Marie","year":"2012","unstructured":"Marie M, Helena JW, Roger T, Luk H, Angela R (2012) Aromatase inhibitors for PCOS: a systematic review and meta-analysis. Hum Reprod Update 18:301\u2013312","journal-title":"Hum Reprod Update"},{"issue":"2","key":"3578_CR75","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3390\/molecules22020209","volume":"22","author":"Y Marunaka","year":"2017","unstructured":"Marunaka Y, Marunaka R, Sun H, Yamamoto T, Kanamura N, Inui T, Taruno A (2017) Actions of Quercetin, a Polyphenol, on Blood Pressure. Molecules 22(2):209. https:\/\/doi.org\/10.3390\/molecules22020209","journal-title":"Molecules"},{"key":"3578_CR76","doi-asserted-by":"publisher","first-page":"428","DOI":"10.2174\/1871530322666220827141203","volume":"23","author":"L Massaro","year":"2023","unstructured":"Massaro L, Raguzzini A, Aiello P, Valencia D (2023) The potential role of naringin and naringenin as nutraceuticals against metabolic syndrome. Endocr Metab Immune Disord-Drug Targets 23:428\u2013445. https:\/\/doi.org\/10.2174\/1871530322666220827141203","journal-title":"Endocr Metab Immune Disord-Drug Targets"},{"key":"3578_CR77","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/cen.14983","volume":"100","author":"JM Melin","year":"2024","unstructured":"Melin JM, Forslund M, Alesi SJ, Piltonen T, Romualdi D, Spritzer PM, Tay CT, Pena AS, Witchel SF, Mousa A, Teede HJ (2024) Effects of different insulin sensitisers in the management of polycystic ovary syndrome: A systematic review and meta-analysis. Clin Endocrinol 100:149\u2013163. https:\/\/doi.org\/10.1111\/cen.14983","journal-title":"Clin Endocrinol"},{"key":"3578_CR78","doi-asserted-by":"publisher","first-page":"471","DOI":"10.2337\/dc06-0618","volume":"30","author":"C Meyer","year":"2007","unstructured":"Meyer C, McGrath BP, Teede HJ (2007) Effects of medical therapy on insulin resistance and the cardiovascular system in polycystic ovary syndrome. Diabetes Care 30:471\u2013478. https:\/\/doi.org\/10.2337\/dc06-0618","journal-title":"Diabetes Care"},{"key":"3578_CR79","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.mce.2014.09.010","volume":"408","author":"W Miller","year":"2015","unstructured":"Miller W, Tee M (2015) The post-translational regulation of 17, 20 lyase activity. Mol Cell Endocrinol 408:99\u2013106","journal-title":"Mol Cell Endocrinol"},{"key":"3578_CR80","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1007\/s12020-014-0426-4","volume":"49","author":"A Moini","year":"2015","unstructured":"Moini A, KananiM KL, Hosseini R, Hosseini L (2015) Effect of orlistat on weight loss, hormonal and metabolic profiles in women with polycystic ovarian syndrome: a randomized double-blind placebo-controlled trial. Endocrine 49:286\u2013289. https:\/\/doi.org\/10.1007\/s12020-014-0426-4","journal-title":"Endocrine"},{"key":"3578_CR81","doi-asserted-by":"publisher","first-page":"121074","DOI":"10.1016\/j.lfs.2022.121074","volume":"31","author":"AG Mukherjee","year":"2022","unstructured":"Mukherjee AG, Wanjari UR, Nagarajan D, Chakraborty R, Renu K, Dey A, Vellingiri B, Gopalakrishnan AV (2022) Letrozole: Pharmacology, toxicity and potential therapeutic effects. Life Sci 31:121074. https:\/\/doi.org\/10.1016\/j.lfs.2022.121074","journal-title":"Life Sci"},{"key":"3578_CR82","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.rbmo.2009.12.012","volume":"20","author":"A Nasr","year":"2010","unstructured":"Nasr A (2010) Effect of N-acetyl-cysteine after ovarian drilling in clomiphene citrate-resistant PCOS women: a pilot study. Reprod Biomed Online 20:403\u2013409. https:\/\/doi.org\/10.1016\/j.rbmo.2009.12.012","journal-title":"Reprod Biomed Online"},{"key":"3578_CR83","first-page":"658","volume":"19","author":"H Nasri","year":"2014","unstructured":"Nasri H, Rafieian-Kopaei M (2014) Metformin: Current knowledge. J Res Med Sci 19:658\u2013664","journal-title":"J Res Med Sci"},{"key":"3578_CR84","doi-asserted-by":"publisher","first-page":"3483","DOI":"10.1016\/j.sjbs.2021.03.014","volume":"28","author":"K Nazeer","year":"2021","unstructured":"Nazeer K, Munawar Lone N, Sadique S, Sultan S, Zia Eupash A, Riaz S (2021) Association of Angiotensin-Converting Enzyme gene polymorphism in Pakistani women with the atypical steroidogenesis in Polycystic ovarian syndrome: A case-control study. Saudi J Biol Sci 28:3483\u20133489. https:\/\/doi.org\/10.1016\/j.sjbs.2021.03.014","journal-title":"Saudi J Biol Sci"},{"key":"3578_CR85","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1002\/ptr.6904","volume":"35","author":"R Negahdari","year":"2021","unstructured":"Negahdari R, Bohlouli S, Sharifi S, MalekiDizaj S, RahbarSaadat Y, Khezri K, Jafari S, Ahmadian E, GorbaniJahandizi N, Raeesi S (2021) Therapeutic benefits of rutin and its nanoformulations. Phytother Res 35:1719\u20131738. https:\/\/doi.org\/10.1002\/ptr.6904","journal-title":"Phytother Res"},{"key":"3578_CR86","doi-asserted-by":"publisher","first-page":"670155","DOI":"10.3389\/fphar.2021.670155","volume":"12","author":"A Nusca","year":"2021","unstructured":"Nusca A, Tuccinardi D, Pieralice S, Giannone S, Carpenito M, Monte L, Watanabe M, Cavallari I, Maddaloni E, Ussia GP, Manfrini S (2021) Platelet effects of anti-diabetic therapies: new perspectives in the management of patients with diabetes and cardiovascular disease. Front Pharmacol 12:670155. https:\/\/doi.org\/10.3389\/fphar.2021.670155","journal-title":"Front Pharmacol"},{"key":"3578_CR87","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1530\/EC-16-0113","volume":"6","author":"M Nylander","year":"2017","unstructured":"Nylander M, Fr\u00f8ssing S, Kistorp C, Faber J, Skouby SO (2017) Liraglutide in polycystic ovary syndrome: a randomized trial, investigating effects on thrombogenic potential. Endocr Connect 6:89\u201399. https:\/\/doi.org\/10.1530\/EC-16-0113","journal-title":"Endocr Connect"},{"issue":"6","key":"3578_CR88","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1177\/0960327113504790","volume":"33","author":"MT Olaleye","year":"2014","unstructured":"Olaleye MT, Crown OO, Akinmoladun AC, Akindahunsi AA (2014) Rutin and quercetin show greater efficacy than nifedipin in ameliorating hemodynamic, redox, and metabolite imbalances in sodium chloride-induced hypertensive rats. Hum Exp Toxicol 33(6):602\u2013608. https:\/\/doi.org\/10.1177\/0960327113504790","journal-title":"Hum Exp Toxicol"},{"key":"3578_CR89","volume-title":"Sodium-Glucose Transport Protein 2 (SGLT2) Inhibitors","author":"I Padda","year":"2022","unstructured":"Padda I, Mahtani A, Parmar M (2022) Sodium-Glucose Transport Protein 2 (SGLT2) Inhibitors. StatPerals, Treasure Island"},{"issue":"12","key":"3578_CR90","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.3390\/biom11121825","volume":"11","author":"A Pannu","year":"2021","unstructured":"Pannu A, Sharma PC, Thakur VK, Goyal RK (2021) Emerging Role of Flavonoids as the Treatment of Depression. Biomolecules 11(12):1825. https:\/\/doi.org\/10.3390\/biom11121825","journal-title":"Biomolecules"},{"key":"3578_CR91","doi-asserted-by":"publisher","first-page":"391","DOI":"10.3109\/09513590.2012.754876","volume":"29","author":"R Paradisi","year":"2013","unstructured":"Paradisi R, Fabbri R, Battaglia C, Venturoli S (2013) Ovulatory effects of flutamide in the polycystic ovary syndrome. Gynecol Endocrinol 29:391\u2013395. https:\/\/doi.org\/10.3109\/09513590.2012.754876","journal-title":"Gynecol Endocrinol"},{"key":"3578_CR92","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1210\/jc.2006-1582","volume":"92","author":"L Pellatt","year":"2007","unstructured":"Pellatt L, Hanna L, Brincat M, Galea R, Brain H, Whitehead S, Mason H (2007) Granulosa cell production of anti-M\u00fcllerian hormone is increased in polycystic ovaries. J Clin Endocrinol Metab 92:240\u2013245. https:\/\/doi.org\/10.1210\/jc.2006-1582","journal-title":"J Clin Endocrinol Metab"},{"key":"3578_CR93","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1080\/07853890.2022.2034933","volume":"54","author":"F Peng","year":"2022","unstructured":"Peng F, Hu Y, Peng S, Zeng N, Shi L (2022) Apigenin exerts protective effect and restores ovarian function in dehydroepiandrosterone induced polycystic ovary syndrome rats: a biochemical and histological analysis. Ann Med 54:578\u2013587. https:\/\/doi.org\/10.1080\/07853890.2022.2034933","journal-title":"Ann Med"},{"key":"3578_CR94","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s40618-019-01133-3","volume":"43","author":"A Podfigurna","year":"2020","unstructured":"Podfigurna A, Meczekalski B, Petraglia F, Luisi S (2020) Clinical, hormonal and metabolic parameters in women with PCOS with different combined oral contraceptives (containing chlormadinone acetate versus drospirenone). J Endocrinol Invest 43:483\u2013492. https:\/\/doi.org\/10.1007\/s40618-019-01133-3","journal-title":"J Endocrinol Invest"},{"key":"3578_CR95","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.neulet.2013.06.060","volume":"557","author":"TJ Price","year":"2013","unstructured":"Price TJ, Dussor G (2013) AMPK: An emerging target for modification of injury-induced pain plasticity. Neurosci Lett 557:9\u201318. https:\/\/doi.org\/10.1016\/j.neulet.2013.06.060","journal-title":"Neurosci Lett"},{"key":"3578_CR96","doi-asserted-by":"publisher","first-page":"912","DOI":"10.2310\/JIM.0b013e31821bfd9c","volume":"59","author":"B Rashidi","year":"2011","unstructured":"Rashidi B, Abediasl J, Tehraninejad E, Rahmanpour H, Sills ES (2011) Simvastatin effects on androgens, inflammatory mediators, and endogenous pituitary gonadotropins among patients with PCOS undergoing IVF: results from a prospective, randomized, placebo-controlled clinical trial. J Investig Med 59:912\u2013916. https:\/\/doi.org\/10.2310\/JIM.0b013e31821bfd9c","journal-title":"J Investig Med"},{"key":"3578_CR97","doi-asserted-by":"publisher","first-page":"3665","DOI":"10.3390\/nu13103665","volume":"13","author":"M Rondanelli","year":"2021","unstructured":"Rondanelli M, Riva A, Petrangolini G, Allegrini P, Giacosa A, Fazia T, Bernardinelli L, Gasparri C, Peroni G, Perna S (2021) Berberine phospholipid is an effective insulin sensitizer and improves metabolic and hormonal disorders in women with polycystic Ovary Syndrome: A one-group pretest-post-test explanatory study. Nutrients 13:3665. https:\/\/doi.org\/10.3390\/nu13103665","journal-title":"Nutrients"},{"key":"3578_CR98","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1007\/s40618-016-0466-0","volume":"39","author":"C Sabbadin","year":"2016","unstructured":"Sabbadin C, Andrisani A, Zermiani M, Don\u00e0 G, Bordin L, Ragazzi E, Boscaro M, Ambrosini G, Armanini D (2016) Spironolactone and intermenstrual bleeding in polycystic ovary syndrome with normal BMI. J Endocrinol Investig 39:1015\u20131021. https:\/\/doi.org\/10.1007\/s40618-016-0466-0","journal-title":"J Endocrinol Investig"},{"key":"3578_CR99","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.euros.2023.04.009","volume":"52","author":"A Saffar","year":"2023","unstructured":"Saffar A, Xu H, O\u2019brien J, Kelly J, Murphy B, Lawrentschuk D (2023) US Food and Drug Administration warning regarding finasteride and suicidal ideation: what should urologists know. Eur Urol Open Sci 52:4\u20136","journal-title":"Eur Urol Open Sci"},{"issue":"2","key":"3578_CR100","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jash.2017.12.002","volume":"12","author":"A Sahebkar","year":"2018","unstructured":"Sahebkar A, Simental-Mendia LE, Kovanen PT, Pedone C, Simental-Mendia M, Cicero AF (2018) Effects of orlistat on blood pressure: a systematic review and meta-analysis of 27 randomized controlled clinical trials. J Am Soc Hypertens 12(2):80\u201396. https:\/\/doi.org\/10.1016\/j.jash.2017.12.002","journal-title":"J Am Soc Hypertens"},{"key":"3578_CR101","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.colsurfb.2016.04.016","volume":"144","author":"N Saini","year":"2016","unstructured":"Saini N, Sodhi RK, Bajaj L, Pandey RS, Jain UK, Katare OP, Madan J (2016) Intravaginal administration of metformin hydrochloride loaded cationic niosomes amalgamated with thermosensitive gel for the treatment of polycystic ovary syndrome: In vitro and in vivo studies. Colloids Surf B 144:161\u2013169. https:\/\/doi.org\/10.1016\/j.colsurfb.2016.04.016","journal-title":"Colloids Surf B"},{"key":"3578_CR102","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1134\/s1990519x21040088","volume":"15","author":"Z Salimi","year":"2021","unstructured":"Salimi Z, Moradpour F, Zarei F, Rashidi Z, Khazaei MR, Ahmadi SM (2021) The effect of blockade of androgen receptors by flutamide on learning and memory, synaptic plasticity and behavioral performances: A review study. Cell Tiss Biol 15:337\u2013346. https:\/\/doi.org\/10.1134\/s1990519x21040088","journal-title":"Cell Tiss Biol"},{"key":"3578_CR103","doi-asserted-by":"publisher","first-page":"9913179","DOI":"10.1155\/2021\/9913179","volume":"2021","author":"A Satari","year":"2021","unstructured":"Satari A, Ghasemi S, Habtemariam S, Asgharian S, Lorigooini Z (2021) Rutin: A flavonoid as an effective sensitizer for anticancer therapy; Insights into multifaceted mechanisms and applicability for combination therapy. Evid Based Complement Alternat Med 2021:9913179. https:\/\/doi.org\/10.1155\/2021\/9913179","journal-title":"Evid Based Complement Alternat Med"},{"issue":"5","key":"3578_CR104","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.4103\/0028-3886.299154","volume":"68","author":"M Sayyah","year":"2020","unstructured":"Sayyah M, Shirbandi K, Rahim F, Ganji R (2020) Statin for migraine headache: is it worthwhile? Neurol India 68(5):1003\u20131007. https:\/\/doi.org\/10.4103\/0028-3886.299154","journal-title":"Neurol India"},{"key":"3578_CR105","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1080\/09513590.2018.1490405","volume":"34","author":"E Seyam","year":"2018","unstructured":"Seyam E, Hefzy E (2018) Long-term effects of combined simvastatin and metformin treatment on the clinical abnormalities and ovulation dysfunction in single young women with polycystic ovary syndrome. Gynecol Endocrinol 34:1073\u20131080. https:\/\/doi.org\/10.1080\/09513590.2018.1490405","journal-title":"Gynecol Endocrinol"},{"key":"3578_CR106","doi-asserted-by":"publisher","first-page":"1153289","DOI":"10.3389\/fendo.2023.1153289","volume":"14","author":"M Shah","year":"2023","unstructured":"Shah M, Shrivastva V, Mir M, Sheikh W, Ganie M, Rather G (2023) Effect of quercetin on steroidogenesis and folliculogenesis in ovary of mice with experimentally-induced polycystic ovarian syndrome. Front Endocrinol 14:1153289","journal-title":"Front Endocrinol"},{"key":"3578_CR107","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1080\/13697130500330382","volume":"8","author":"R Sitruk-Ware","year":"2005","unstructured":"Sitruk-Ware R (2005) Pharmacology of different progestogens: the special case of drospirenone. Climacteric 8:4\u201312. https:\/\/doi.org\/10.1080\/13697130500330382","journal-title":"Climacteric"},{"key":"3578_CR108","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s11064-022-03775-x","volume":"48","author":"NA Soliman","year":"2023","unstructured":"Soliman NA, Abdel Ghafar MT, AbuoHashish NA, Ibrahim MA, Eid AM, El-Gohary RM, Abo El Gheit RE, Elshamy AM (2023) The possible role of naringenin in the prevention of alcohol-induced neurochemical and neurobehavioral deficits. Neurochem Res 48:537\u2013550. https:\/\/doi.org\/10.1007\/s11064-022-03775-x","journal-title":"Neurochem Res"},{"key":"3578_CR109","doi-asserted-by":"publisher","first-page":"e145","DOI":"10.15190\/d.2022.4","volume":"10","author":"MR Somagutta","year":"2022","unstructured":"Somagutta MR, Jain M, Uday U, Pendyala SK, Mahadevaiah A, Mahmutaj G, Jarapala N, Gad MA, Srinivas PM, Sasidharan N, Mustafa N (2022) Novel antidiabetic medications in polycystic ovary syndrome. Discoveries (Craiova, Romania) 10:e145. https:\/\/doi.org\/10.15190\/d.2022.4","journal-title":"Discoveries (Craiova, Romania)"},{"key":"3578_CR110","doi-asserted-by":"publisher","first-page":"101287","DOI":"10.1016\/j.ctcp.2020.101287","volume":"42","author":"MT Suadoni","year":"2021","unstructured":"Suadoni MT, Atherton I (2021) Berberine for the treatment of hypertension: A systematic review. Complement Ther Clin Pract 42:101287. https:\/\/doi.org\/10.1016\/j.ctcp.2020.101287","journal-title":"Complement Ther Clin Pract"},{"key":"3578_CR111","doi-asserted-by":"publisher","first-page":"113540","DOI":"10.1016\/j.jep.2020.113540","volume":"267","author":"U Suriyakalaa","year":"2021","unstructured":"Suriyakalaa U, Ramachandran R, Doulathunnisa JA, Aseervatham SB, Sankarganesh D, Kamalakkannan S, Kadalmani B, Angayarkanni J, Akbarsha MA, Achiraman S (2021) Upregulation of Cyp19a1 and PPAR-\u03b3 in ovarian steroidogenic pathway by Ficusreligiosa: A potential cure for polycystic ovary syndrome. J Ethnopharmacol 267:113540. https:\/\/doi.org\/10.1016\/j.jep.2020.113540","journal-title":"J Ethnopharmacol"},{"key":"3578_CR112","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.fertnstert.2009.01.150","volume":"94","author":"M Tartagni","year":"2010","unstructured":"Tartagni M, Cicinelli E, De Pergola G, Lavopa C, Di Naro E, De Salvia MA, Loverro G (2010) Effect of finasteride on ovulation induction in nonresponder (hyperandrogenic) polycystic ovary syndrome (PCOS) women. Fertil Steril 94:247\u2013249. https:\/\/doi.org\/10.1016\/j.fertnstert.2009.01.150","journal-title":"Fertil Steril"},{"key":"3578_CR113","doi-asserted-by":"publisher","first-page":"817849","DOI":"10.1155\/2015\/817849","volume":"2015","author":"D Thakker","year":"2015","unstructured":"Thakker D, Raval A, Patel I, Walia R (2015) N-acetylcysteine for polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled clinical trials. Obstet Gynecol Int 2015:817849. https:\/\/doi.org\/10.1155\/2015\/817849","journal-title":"Obstet Gynecol Int"},{"issue":"1","key":"3578_CR114","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3892\/etm.2016.3958","volume":"13","author":"M Theodotou","year":"2017","unstructured":"Theodotou M, Fokianos K, Mouzouridou A, Konstantinou C, Aristotelous A, Prodromou D, Chrysikou A (2017) The effect of resveratrol on hypertension: A clinical trial. Exp Ther Med 13(1):295\u2013301. https:\/\/doi.org\/10.3892\/etm.2016.3958","journal-title":"Exp Ther Med"},{"key":"3578_CR115","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3390\/nu15020385","volume":"15","author":"S Thomas","year":"2023","unstructured":"Thomas S, Jha N, Jha S, Sadek B, Ojha S (2023a) Pharmacological and molecular insight on the cardioprotective role of apigenin. Nutrients 15:385","journal-title":"Nutrients"},{"issue":"2","key":"3578_CR116","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3390\/nu15020385","volume":"15","author":"SD Thomas","year":"2023","unstructured":"Thomas SD, Jha NK, Jha SK, Sadek B, Ojha S (2023b) Pharmacological and Molecular Insight on the Cardioprotective Role of Apigenin. Nutrients 15(2):385. https:\/\/doi.org\/10.3390\/nu15020385","journal-title":"Nutrients"},{"key":"3578_CR117","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3109\/09513590.2012.736557","volume":"29","author":"C Vosnakis","year":"2013","unstructured":"Vosnakis C, Georgopoulos N, Rousso D, Mavromatidis G, Katsikis I, Roupas N (2013) Diet, physical exercise and Orlistat administration increase serum anti- Mullerian hormone (AMH) levels in women with polycystic ovary syndrome (PCOS). Gynecol Endocrinol 29:242\u2013245","journal-title":"Gynecol Endocrinol"},{"key":"3578_CR118","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1530\/EJE-11-0616","volume":"166","author":"W Wei","year":"2012","unstructured":"Wei W, Zhao H, WangA SM, Liang K, Deng H, Ma Y, Zhang Y, Zhang H, Guan Y (2012) A clinical study on the short-term effect of berberine in comparison to metformin on the metabolic characteristics of women with polycystic ovary syndrome. Eur J Endocrinol 166:99\u2013105. https:\/\/doi.org\/10.1530\/EJE-11-0616","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"3578_CR119","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.sjpain.2013.12.003","volume":"5","author":"H Wernze","year":"2014","unstructured":"Wernze H, Herdegen T (2014) Long-term efficacy of spironolactone on pain, mood, and quality of life in women with fibromyalgia: An observational case series. Scand J Pain 5(2):63\u201371. https:\/\/doi.org\/10.1016\/j.sjpain.2013.12.003","journal-title":"Scand J Pain"},{"key":"3578_CR120","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.3389\/fnins.2019.01097","volume":"13","author":"W Wu","year":"2019","unstructured":"Wu W, Ji X, Zhao Y (2019) Emerging roles of long non-coding RNAs in chronic neuropathic pain. Front Neurosci 13:1097. https:\/\/doi.org\/10.3389\/fnins.2019.01097","journal-title":"Front Neurosci"},{"key":"3578_CR121","doi-asserted-by":"publisher","first-page":"e37432","DOI":"10.1097\/MD.0000000000037432","volume":"103","author":"W Xia","year":"2024","unstructured":"Xia W, Yu H, Lei X, Wen P (2024) Effect of liraglutide on cardiac function in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of double-blind, randomized, placebo-controlled trials. Medicine 103:e37432. https:\/\/doi.org\/10.1097\/MD.0000000000037432","journal-title":"Medicine"},{"key":"3578_CR122","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12958-016-0203-8","volume":"14","author":"R Yang","year":"2016","unstructured":"Yang R, YangS LR, Liu P, Qiao J, Zhang Y (2016) Effects of hyperandrogenism on metabolic abnormalities in patients with polycystic ovary syndrome: a meta-analysis. Reprod Biol Endocrinol 14:67. https:\/\/doi.org\/10.1186\/s12958-016-0203-8","journal-title":"Reprod Biol Endocrinol"},{"key":"3578_CR123","doi-asserted-by":"publisher","first-page":"8825387","DOI":"10.1155\/2020\/8825387","volume":"2020","author":"D Yang","year":"2020","unstructured":"Yang D, Wang T, Long M, Li P (2020) Quercetin: Its main pharmacological activity and potential application in clinical medicine. Oxid Med Cell Longev 2020:8825387. https:\/\/doi.org\/10.1155\/2020\/8825387","journal-title":"Oxid Med Cell Longev"},{"key":"3578_CR124","doi-asserted-by":"publisher","first-page":"676133","DOI":"10.3389\/fendo.2021.676133","volume":"12","author":"AM Yang","year":"2021","unstructured":"Yang AM, Cui N, Sun YF, Hao GM (2021) Letrozole for female infertility. Front Endocrinol 12:676133. https:\/\/doi.org\/10.3389\/fendo.2021.676133","journal-title":"Front Endocrinol"},{"key":"3578_CR125","first-page":"1","volume":"16","author":"T Yin","year":"2019","unstructured":"Yin T, Wen J, Wei W, Li C (2019) Effect of berberine on endometrial PPARs and endocrine metabolism of PCOS rat. Med Med Innov China 16:1\u20136","journal-title":"Med Med Innov China"},{"key":"3578_CR126","doi-asserted-by":"publisher","first-page":"9563","DOI":"10.1096\/fj.202000605RR","volume":"34","author":"C Zhang","year":"2020","unstructured":"Zhang C, Hu J, Wang W, Sun Y, Sun K (2020a) HMGB1-induced aberrant autophagy contributes to insulin resistance in granulose cells in PCOS. FASEB J 34:9563\u20139574","journal-title":"FASEB J"},{"key":"3578_CR127","doi-asserted-by":"publisher","first-page":"104544","DOI":"10.1016\/j.yrtph.2019.104544","volume":"110","author":"N Zhang","year":"2020","unstructured":"Zhang N, Liu X, Zhuang L, Liu X, Zhao H, Shan Y, Liu Z, Li F, Wang Y, Fang J (2020b) Berberine decreases insulin resistance in a PCOS rats by improving GLUT4: Dual regulation of the PI3K\/AKT and MAPK pathways. Regul Toxicol Pharmacology 110:104544. https:\/\/doi.org\/10.1016\/j.yrtph.2019.104544","journal-title":"Regul Toxicol Pharmacology"},{"key":"3578_CR128","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41392-020-00213-8","volume":"5","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, Zhou L, Xie N, Nice EC, Zhang T, Cui Y, Huang C (2020c) Overcoming cancer therapeutic bottleneck by drug repurposing. Signal Transduct Target Ther 5:113. https:\/\/doi.org\/10.1038\/s41392-020-00213-8","journal-title":"Signal Transduct Target Ther"},{"key":"3578_CR129","doi-asserted-by":"publisher","first-page":"111468","DOI":"10.1016\/j.biopha.2021.111468","volume":"138","author":"SW Zhang","year":"2021","unstructured":"Zhang SW, Zhou J, Gober HJ, Leung WT, Wang L (2021) Effect and mechanism of berberine against polycystic ovary syndrome. Biomed Pharmacother 138:111468. https:\/\/doi.org\/10.1016\/j.biopha.2021.111468","journal-title":"Biomed Pharmacother"},{"key":"3578_CR130","doi-asserted-by":"publisher","first-page":"e058260","DOI":"10.1136\/bmjopen-2021-058260","volume":"12","author":"J Zhang","year":"2022","unstructured":"Zhang J, Xing C, He B (2022) Sodium-glucose cotransporter-2 inhibitors for improving endocrine and metabolic profiles in overweight and obese individuals with polycystic ovary syndrome: a meta-analysis protocol. BMJ Open 12:e058260. https:\/\/doi.org\/10.1136\/bmjopen-2021-058260","journal-title":"BMJ Open"},{"key":"3578_CR131","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13048-022-01091-0","volume":"16","author":"H Zhao","year":"2023","unstructured":"Zhao H, Zhang J, Cheng X, Nie X, He B (2023) Insulin resistance in polycystic ovary syndrome across various tissues: an updated review of pathogenesis, evaluation, and treatment. J Ovarian Res 16:9. https:\/\/doi.org\/10.1186\/s13048-022-01091-0","journal-title":"J Ovarian Res"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03578-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-024-03578-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03578-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T02:03:44Z","timestamp":1744164224000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-024-03578-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,9]]},"references-count":131,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["3578"],"URL":"https:\/\/doi.org\/10.1007\/s00210-024-03578-7","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,9]]},"assertion":[{"value":"21 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}